Endocardial Solutions, Inc.
This article was originally published in The Gray Sheet
Private placement of approximately 2.5 mil. shares of common stock raises about $7.3 mil. Repayment of a $7 mil. loan to EnSite 3000 atrial arrhythmia mapping system marketing partner Medtronic was simultaneously announced by the company. U.S. Bancorp Piper Jaffray was agent for the offering
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.